The FDA has granted Breakthrough Therapy designation to BPL-003 (mebufotenin benzoate) nasal spray for adults with treatment-resistant depression.
Mission Prep, a specialized adolescent mental health clinic with centers across California and Virginia, has released a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback